Patient Guide: A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06396091
Status: 🟢 Enrolling Now
Condition: Metastatic Pancreatic Adenocarcinoma
Phase: PHASE1

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Fullerton, California
  • • Washington D.C., District of Columbia
  • • Louisville, Kentucky
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer - Join Clinical Trial NCTNCT06396091

How to Join This Clinical Trial - NCTNCT06396091

Learn how to participate in this PHASE1 trial studying an investigational therapy for Metastatic Pancreatic Adenocarcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Pancreatic Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Pancreatic Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06396091 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Fullerton, California 92835 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20016 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40202 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: RECRUITING

Clinical Research Site

Seattle, Washington 98101 - United States

Status: RECRUITING

Clinical Research Site

Spokane, Washington 99204 - United States

Status: WITHDRAWN

Clinical Research Site

Tacoma, Washington 98405 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Metastatic Pancreatic Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships